Pendapatan operasional sadurunge ngurangi amortisasi: Alkermes PLC (ALKS)

Patent frictions and declining royalties are putting pressure on Alkermes plc (ALKS), yet the net operating income before depreciation reflects the business's resilience. The value of 174.90 determines this parameter level. Stability is sustained by a strong reputation in treating neuroses and the protection of unique drug delivery methods, which require colossal expenditures for certification and research.

Bathi operasional EBITDA Alkermes plc (ALKS): kanggo periode 23.11.2025 - 10.11.2026

Ringkesan rincian data analitis Alkermes (ALKS)

- rega saham lan konsensus proyeksi valuasi:

Bagan kutipan Alkermes Corp|ALKS - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Alkermes|ALKS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Nilai Aset Bersih saben Saham Alkermes|ALKS - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih alkermes.com|ALKS - Total Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

- rincian bathi lan kelipatan pasar:

ALKS - Bathi resik|Bathi resik sing dikarepake Alkermes plc|ALKS - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi alkermes.com|ALKS - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alkermes|ALKS - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Alkermes|ALKS - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan alkermes.com|ALKS - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Alkermes plc

Ringkesan analitik perusahaan:ALKS (Alkermes Corp)

Investors are verifying the financial stability of Alkermes plc (ALKS) through cash flow analysis, which confirms the business's ability to generate real liquidity. The EBITDA_Co trend on this chart reflects the net funds derived from the sale of psychotropic drugs, where the efficiency of specialized logistics and route control converts directly into operating profit, signaling either business growth or the risk of asset overheating.

Pesaing Alkermes plc (ALKS)